PHOENIX – February 14, 2019 /Canna Newswire/ – This week Cannasphere Biotech launches its new Lipofusion™ Hydro Concentrate, a patent pending innovation in nanoliposomal encapsulation, which research has shown to increase absorption of CBD by as much as 80 percent. This water soluble (miscible), liquid CBD concentrate is designed to be used in a wide variety of liquid formulas and products including sublingual sprays. It contains 5 percent active broad-spectrum CBD.
“The cannabinoid market is maturing and both manufacturers and consumers alike are beginning to understand that bioactive nutrient absorption can be improved upon. For example, CBD absorption can be tremendously improved if the appropriate technology is applied. That’s why leveraging nanoliposomal technology like Lipofusion™ to deliver cannabinoids is so important. It helps to overcome absorption issues and provides many advantages such as maximized bioavailability, rapid onset, and sustained release,” said Andrew Wood, Scientific Advisor at Cannasphere Biotech. “These advantages give our customers a meaningful competitive edge in the market.”
Consistent with the company’s Lipofusion™ CBD Powder, its new Lipofusion™ Hydro CBD Concentrate is broad spectrum—considered to be far superior to an isolate. Broad spectrum CBD brings with it all the benefits of the entourage effect which includes valuable terpenes, essential oils, and other cannabinoids. That said, there is no detectable THC in any of the company’s products (verified by Certificates of Analysis).
About Cannasphere Biotech
Cannasphere Biotech combines the power of hemp-derived Cannabidiol (CBD) with its patent pending Lipofusion™ delivery technology to maximize bioavailability while facilitating rapid onset and sustained release. The company offers private label products, product development services, and manufacturing ready Lipofusion™ CBD which is water soluble and can be utilized as a raw ingredient (in either powder or liquid form) in a wide variety of products. All of the company’s products undergo rigorous testing for purity, potency, safety and efficacy at independent laboratories and are manufactured in a cGMP, FDA-registered facility. The company’s Certificates of Analysis verify that there is no detectable THC in any of its products. For more information please visit www.cannaspherebiotech.com.
# CNW #
Media Contact:
Kelly Wood
Cannasphere Biotech
kelly@cannaspherebiotech.com
+1 (480) 239-0109
